Maze Therapeutics, Inc. (Nasdaq: MAZE), a clinical-stage biopharmaceutical company developing small molecule precision ...

Please provide your email address to receive an email when new articles are posted on . The American Society of Nephrology launched its loan mitigation pilot program, committing $2,700,000 to selected ...

Please provide your email address to receive an email when new articles are posted on . The American Society of Nephrology has announced the second year of its loan mitigation program, which provides ...